Cargando…
1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506426/ http://dx.doi.org/10.1016/j.annonc.2020.08.1757 |
| _version_ | 1783585015719788544 |
|---|---|
| author | Gurizzan, C. Pedersini, R. Fornaro, C. Sardini, C. Zamparini, M. Monteverdi, S. Tovazzi, V. Cosentini, D. Dalla Volta, A. Baggi, A. Turla, A. Di Mauro, P. Lorini, L. Laganà, M. Bianchi, S. Intagliata, S. Consoli, F. Conti, E. Bossi, P. Berruti, A. |
| author_facet | Gurizzan, C. Pedersini, R. Fornaro, C. Sardini, C. Zamparini, M. Monteverdi, S. Tovazzi, V. Cosentini, D. Dalla Volta, A. Baggi, A. Turla, A. Di Mauro, P. Lorini, L. Laganà, M. Bianchi, S. Intagliata, S. Consoli, F. Conti, E. Bossi, P. Berruti, A. |
| author_sort | Gurizzan, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75064262020-09-23 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic Gurizzan, C. Pedersini, R. Fornaro, C. Sardini, C. Zamparini, M. Monteverdi, S. Tovazzi, V. Cosentini, D. Dalla Volta, A. Baggi, A. Turla, A. Di Mauro, P. Lorini, L. Laganà, M. Bianchi, S. Intagliata, S. Consoli, F. Conti, E. Bossi, P. Berruti, A. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506426/ http://dx.doi.org/10.1016/j.annonc.2020.08.1757 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gurizzan, C. Pedersini, R. Fornaro, C. Sardini, C. Zamparini, M. Monteverdi, S. Tovazzi, V. Cosentini, D. Dalla Volta, A. Baggi, A. Turla, A. Di Mauro, P. Lorini, L. Laganà, M. Bianchi, S. Intagliata, S. Consoli, F. Conti, E. Bossi, P. Berruti, A. 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic |
| title | 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic |
| title_full | 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic |
| title_fullStr | 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic |
| title_full_unstemmed | 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic |
| title_short | 1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic |
| title_sort | 1693p accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during sars-cov-2 pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506426/ http://dx.doi.org/10.1016/j.annonc.2020.08.1757 |
| work_keys_str_mv | AT gurizzanc 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT pedersinir 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT fornaroc 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT sardinic 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT zamparinim 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT monteverdis 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT tovazziv 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT cosentinid 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT dallavoltaa 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT baggia 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT turlaa 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT dimaurop 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT lorinil 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT laganam 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT bianchis 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT intagliatas 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT consolif 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT contie 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT bossip 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic AT berrutia 1693paccuratetriagemaybeefficaciousinselectingpatientswhocouldsafelycontinueanticancertherapyduringsarscov2pandemic |